- Home
- MTR vs MBRX Comparison
MTR vs MBRX Comparison
Compare MTR & MBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$3.84
Company Overview
Basic Information| Metric | MTR | MBRX |
|---|---|---|
| Founded | 1979 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.8M | 8.6M |
| IPO Year | N/A | 2016 |
Fundamental Metrics
Financial Performance| Metric | MTR | MBRX |
|---|---|---|
| Price | $4.25 | $3.84 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $105.50 |
| AVG Volume (30 Days) | 12.3K | ★ 608.5K |
| Earning Date | 03-31-2026 | 11-13-2025 |
| Dividend Yield | ★ 5.48% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.23 | N/A |
| Revenue | ★ $623,288.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $18.50 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.03 | $3.63 |
| 52 Week High | $10.42 | $91.25 |
Technical Indicators
Market Signals| Indicator | MTR | MBRX |
|---|---|---|
| Relative Strength Index (RSI) | 39.22 | 50.72 |
| Support Level | $4.03 | $3.74 |
| Resistance Level | $4.54 | $4.24 |
| Average True Range (ATR) | 0.18 | 0.51 |
| MACD | -0.05 | -0.31 |
| Stochastic Oscillator | 23.91 | 5.04 |
Price Performance
Historical Comparison MTR
MBRX
About MTR Mesa Royalty Trust
Mesa Royalty Trust holds net overriding royalty interests in various oil and gas properties located in the: Hugoton field of Kansas, San Juan Basin field of New Mexico, and San Juan Basin Field of Colorado.
About MBRX Moleculin Biotech Inc.
Moleculin Biotech Inc is a clinical stage pharmaceutical company focused on the development of a broad portfolio of drug candidates for the treatment of resistant tumors and viruses. The company's Annamycin program is a next-generation anthracycline designed to avoid multidrug resistance mechanisms with little to no cardiotoxicity.